Treatment of HRD-positive ovarian carcinosarcoma: A case report and literature review.

Lin, Xin Yi; Xu, Huang Zhen; Liang, Chen; Zhao, Ai Yue

Lin, Xin Yi; Xu, Huang Zhen; Liang, Chen; Zhao, Ai Yue.

Afiliação

Lin XY; Department of Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Xu HZ; Department of Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Liang C; Department of Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Zhao AY; Department of Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China. Electronic address: 15715979968@163.com.

Asian J Surg ; 46(12): 6047-6048, 2023 Dec.

Article em En | MEDLINE | ID: mdl-37743176

Assuntos

Carcinossarcoma; Neoplasias Ovarianas; Feminino; Humanos; Neoplasias Ovarianas/cirurgia; Carcinossarcoma/cirurgia

Palavras-chave

Gynecologic tumor; HRD-Positive; Malignant mixed mullerian duct tumor; Ovarian cancer sarcoma; PARP inhibitor

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Carcinossarcoma Limite: Female / Humans Idioma: En Revista: Asian J Surg Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google